Skip to main content

Articles

Perspectives
Ahead of the Curve
Read More
Perspectives
Guiding Employer Management of Specialty Drugs
Read More
Practice Management
Trends in Medicare Part D Medication Therapy Management Eligibility Criteria
Stakeholder Perspective
Is It Time to Revisit Medicare Part D?
Read More
Original Research
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression
Stakeholder Perspective
Counting on a Run of Value-Based Benefit Design
Read More
Practice Management
US Healthcare Annual Spending Estimated to Rise by 5.8% on Average Through 2024
Read More
Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens
Stakeholder Perspective
Impact of Chemotherapy-Induced Nausea and Vomiting Treatment on Patient Outcomes and Resource Utilization
Read More
Value-Based Healthcare Delivery: The Agenda for Oncology
Read More
FDA Approvals
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Read More
Searching for the Tipping Point in Drug Pricing
Read More
FDA Approvals
Oncology Pipeline Full, and Not Just with Immunotherapies
Read More
Page 127 of 244
Results 1261 - 1270 of 2434